T3D Therapeutics Inc. receives FDA IND approval to begin phase 2 clinical study of T3D-959 in Alzheimer’s patients

August 2, 2015

Seniors housing developers compete for Global Award

August 2, 2015

Business partners create housing for aging family members

July 30, 2015

Age care compounds becoming soft crime targets

July 30, 2015